ENDRA Life Sciences (NDRA) Shares Outstanding (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Shares Outstanding (Entity) for 11 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 120.69% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 120.69% YoY), while the FY2025 annual figure was $787020.0, up 289.41% from the prior year.
• Shares Outstanding (Entity) rose to $1.2 million in Q1 2026 per NDRA's latest filing, from $787020.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.2 million in Q1 2026 and bottomed at $1273.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $271788.1 across 5 years, with a median of $6237.0 in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 7.06% — and 2025, when it soared 8914.16%.
• ENDRA Life Sciences' Shares Outstanding (Entity) stood at $1811.0 in 2022, then surged by 100.77% to $3636.0 in 2023, then soared by 5458.47% to $202106.0 in 2024, then soared by 289.41% to $787020.0 in 2025, then jumped by 57.65% to $1.2 million in 2026.
• Business Quant data shows NDRA's Shares Outstanding (Entity) at $1.2 million in Q1 2026, $787020.0 in Q4 2025, and $786902.0 in Q3 2025.